If you're looking for a simple, one-size-fits-all number, youre going to be disappointed
January 2024 Update: Eli Lilly has filed a response opposing the motion to consolidate Mounjaro stomach paralysis lawsuits into a multidistrict litigation with other GLP-1 drugs, claiming that the majority of lawsuits involve Novo Nordisks Ozempic and Wegovy drugs, and that most claims filed to date involve plaintiffs who used the drugs for weight loss
What are the risks of using GLP-1 (Glucagon-like peptide-1) receptor agonists, such as liraglutide (Victoza) or semaglutide (Ozempic), in a patient with decompensated cirrhosis and a history of multiple thyroid nodules, and why are they avoided at this stage?
Trusted medical care, close to Phoenix
After seeing his wife's weight loss success, Ethan Smith told "Impact" that he wanted to follow in her footsteps and improve his health